Fundraising Fox

Picture

South San Francisco, US · Founded 2022 · Delaware corporation · 5 known investors

noetik.ai

NOETIK builds AI and computational biology platforms to discover and develop cancer therapeutics by combining large-scale multimodal spatial biology data from human tumors with machine learning models. The company serves pharmaceutical and biotech researchers developing cancer drugs, particularly focused on precision oncology and immunotherapy.

AI & Machine LearningBiotechHealthtechin /noetik-inc@noetik_ai

Founders & leadership

JR
Jacob RinaldiExecutive Officer, Director, Promoter
RA
Ronald AlfaExecutive Officer, Director, Promoter
SH
SVP, Head of Research at RecursionCo-founder
VO
VP of Informatics at Parker Institute for Cancer ImmunotherapyCo-founder
CC
Chief Corporate Development Officer at RecursionCo-founder
JH
James HardimanDirector
AS
Amy SchulmanDirector

Investors · 5

Reported raises · per SEC filings

Form D private placements
$40MraisedAug 2024 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James HardimanDirector
  • Jacob RinaldiExecutive Officer, Director, Promoter
  • Ronald AlfaExecutive Officer, Director, Promoter
  • Amy SchulmanDirector
Offering amount
$40M
Amount sold
$40M
First sale
Jul 2024
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$8MraisedSep 2022 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ronald AlfaExecutive Officer, Director, Promoter
  • Jacob RinaldiExecutive Officer, Director, Promoter
  • James HardimanDirector
Offering amount
$8M
Amount sold
$8M
First sale
Aug 2022
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.